Specialty pharma Hyperion raises $15M in debt, names execs
See our story on this South San Francisco, Calif., specialty pharmaceutical company in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Microsoft’s HealthVault lets you manage your health records — badly
Previous Story: Mark Jacobstein: Out of the Loopt, into CRV
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.